"The round is led by Heal Capital with participation from Rubio Impact Ventures . Earlier backer Chris Oomen, chair of Optiverder, has also participated. The funding will support expansion into Germany, the UK, and Spain this year and continued development of the company's consumer product."
"Ditto was founded by CEO Tobias Lensing alongside co-founders Bart Voorn and Merlijn van Breugel after Lensing accompanied a friend with stage-4 bile-duct cancer to an oncology appointment and realised the two had walked away with materially different understandings of what the doctor said. The company says patients typically remember 20% to 40% of what is communicated in a medical consultation."
"The product is a mobile app that records the consultation with the patient's consent and generates a structured, plain-language summary that the patient can revisit, share with family, and use to prepare for follow-up appointments. The position runs counter to the prevailing direction of AI in healthcare, which has focused on clinician-side tools for note-taking, triage, and chart-completion. Ditto argues that the lower-cost, higher-leverage opportunity is on the patient side."
"Lensing said in the announcement that the company's design choice is the strategic point. "Almost every AI company in healthcare today is building for doctors," Lensing said. "All useful. But nobody is building for the person on the other side of the de"
Ditto secured a funding round led by Heal Capital with participation from Rubio Impact Ventures and earlier backer Chris Oomen. The funding supports expansion into Germany, the UK, and Spain and continued development of the company’s consumer product. Ditto was founded by CEO Tobias Lensing with co-founders Bart Voorn and Merlijn van Breugel after a personal experience highlighted differences in how patients understood medical appointments. The company states that patients typically remember 20% to 40% of what is communicated during consultations. Its mobile app records consultations with consent and generates structured, plain-language summaries that patients can review, share with family, and use for follow-up preparation. The product launched in the Netherlands with Patient Federation support, reached 10,000 downloads in under two weeks, is approaching 100,000 users, and has strong app ratings and an innovation award.
Read at TNW | Health-Tech
Unable to calculate read time
Collection
[
|
...
]